19 December 2001
No Evidence for Participation of Non-Adrenergic Non-Cholinergic Subtances in Brain Death-Related Hemodynamic Deterioration of the Feline Potential Heart Donor
GJ. Brandon Bravo Bruinsma, J.J. Bredee, T. J.C. Ruigrok, Van Echteld, J. H.H. ThijssenAnn Transplant 2001; 6(4): 43-47 :: ID: 497839
Abstract
Objective: The onset of brain death (BD) is associated with a hyperdynamic cardiovascular response caused by the acute sympathetic release of catecholamines. This is followed by progressive hemodynamic deterioration which may preclude heart donation for transplantation. The mechanism of the hemodynamic collapse is not fully understood. Changes in plasma concentrations of non-adrenergic non-cholinergic (NANC) substances. neuropeptide-Y (NP-Y. a vasoconstrictor) and the vasodilators calcitonin gene-related peptide (CGRP) and substance P (SP). were studied in relation to BD-related hemodynamic alterations. Materials and Methods: Cats (6 BD and 6 controls (C» were studied for 6 h. Heart rat~ (HR) and mean arterial pressure (MAP) were monitored. BD was induced at t = 0 min. At t = -5, 15.60, 180 and 360 min. 5 ml arterial blood samples were taken. The plasma was collected and analyzed. The correlations between MAP and NANC levels were calculated. Results: In the BD cats a maximal and significant increase in HR and MAP was observed at t = 2 min. HR returned to basal levels at t = 20 min and remained at that level. However. MAPdeteriorated progressively to 53:t8 mmHg (p 0.00 I vs C) at / =360 min. NP-Yhad increased from 59.7:t2.5 to 110:t20.2 pmoVI (p 0.05 vsC) at t = 15 min, had returned to basal value at t =60 min and remained at that level. CGR Plevels were lower and SP levels did not change vs C but both showed a trend towards higher levels at t =360 min. The correlations between MAP and NP- Y, CGRP and SP appeared to be not significant. Conclusion: No evidence for participation of NANC substances could be demonstrated in brain death-related hemodynamic deterioration of the feline potential heart donor
Keywords: Brain Death, hemodynamic response, Neuropeptides
In Press
Original article
The Long-Acting Glucagon-Like Peptide-2 Analog Apraglutide Enhances Intestinal Protection and Survival Afte...Ann Transplant In Press; DOI: 10.12659/AOT.945249
Original article
Biopsychosocial Effects of Donor Traits on Heart Transplant RecipientsAnn Transplant In Press; DOI:
Clinical Research
Ten-Year Retrospective Analysis of Continuous Renal Replacement Therapy in Burn Patients: Impact on Surviva...Ann Transplant In Press; DOI:
Original article
Factors Influencing Stress Disorders in Intensive Care Unit (ICU) Patients After Liver Transplantation: A C...Ann Transplant In Press; DOI: 10.12659/AOT.944320
Most Viewed Current Articles
05 Apr 2022 : Original article 13,113
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,260
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,611
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,271
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860